NCT06091306 Qualitative Evaluation of Change Processes in Multifamily Therapy for Adolescents With Anorexia Nervosa
| NCT ID | NCT06091306 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Anorexia Nervosa |
| Study Type | OBSERVATIONAL |
| Enrollment | 138 participants |
| Start Date | 2023-12-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 138 participants in total. It began in 2023-12-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Anorexia nervosa is a characterised disorder which forms part of the wider spectrum of eating disorders. It is a common pathology, particularly in adolescence, with a complex, severe prognosis in both somatic and psychiatric terms, and significant psychosocial consequences, particularly for family relationships. The treatment of anorexia requires a multidisciplinary team of specialists who can offer individual and family-based approaches. International recommendations highlight the encouraging results of family therapy in the treatment of anorexia nervosa in adolescence. Various types of family approach exist, including "Family Based Treatments", which are a specific but highly effective approach, particularly widespread in the United States. Multifamily therapy (MFT), which involves bringing several families together to address the problem of anorexia, has proved effective for several years now. Since January 2019, multifamily therapy has been offered to adolescents aged 12 to 18 who are being followed at the Maison de Solenn-Maison des Adolescents at Cochin hospital, for anorexia nervosa, as well as their families. Each group brings together 5 to 7 families and comprises 10 3-hour sessions, with 3 weeks between each session. 2 groups are offered per year. Multi-family therapy therefore involves 10 to 14 families per year. It complements the other approaches available in the department. To be able to describe the therapeutic processes at work in multifamily groups in order to be able to better describe our therapeutic device and envisage possible modifications. These processes would be broken down into four areas: MFT and its effects on the anorexic symptom, MFT and its effects on the family, MFT as group therapy and ways of improving the MFT system.
Eligibility Criteria
Inclusion Criteria: Families who have taken part in a multifamily group on anorexia nervosa, i.e. : * Parents (or any adult identified as a referent by the teenager), teenagers and siblings (over 6 years old) who have taken part in multi-family therapy (people from the teenager's family who have not taken part in the group will not be included), * Adolescents aged 12 to 20, * Adolescents with anorexia nervosa according to DSM5 criteria, * Adolescents treated at the Maison des Adolescents at Cochin Hospital, * Non-opposition of adolescents, their parents and siblings. It will be possible to include in the study a parent or sibling whose adolescent did not wish to take part in the research but who participated in the MFT group. Exclusion Criteria: * Contraindication to multifamily therapy (i.e. any family situation that makes it impossible to bring parents and children together in family therapy without changing the setting (parents stripped of parental authority, educational removal measure, mediated visits, etc.), * Any patient whose main diagnosis is not anorexia nervosa according to DSM5 criteria. * Patients with an autistic spectrum disorder, a chronic psychotic disorder or an intellectual disability as their primary or secondary diagnosis according to DSM 5. * Participants under curatorship or guardianship * Participants not covered by a Social Security scheme.
Contact & Investigator
Marie-Rose MORO, MD, PhD
STUDY DIRECTOR
University Hospital Cochin, Maison des Adolescents - Youth Department, F-75014 Paris, France
Frequently Asked Questions
Who can join the NCT06091306 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, studying Anorexia Nervosa. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06091306 currently recruiting?
Yes, NCT06091306 is actively recruiting participants. Contact the research team at salome.grandclerc@aphp.fr for enrollment information.
Where is the NCT06091306 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT06091306 clinical trial?
NCT06091306 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Marie-Rose MORO, MD, PhD at University Hospital Cochin, Maison des Adolescents - Youth Department, F-75014 Paris, France. The trial plans to enroll 138 participants.